Skip to content

Silver Russell Syndrome Due To 7p11 2p13 Microduplication C5679840

Published: July 22, 2026Updated: August 20, 2026

A form of this condition resulting from duplications in specific regions of chromosome 7, affecting growth patterns and development. Care involves growth monitoring and supportive interventions.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(congenital)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Targeted Growth Hormone Therapy

Growth hormone therapy adapted for the specific 7p11.2p13 microduplication genetic subtype which may have distinct growth response patterns. Involves careful titration based on growth response and IGF-1 levels with attention to the chromosomal context.

medication
3

Aggressive Nutritional Intervention

Comprehensive nutritional rehabilitation program including caloric supplementation, frequent feeding schedules, and appetite stimulation strategies to address severe intrauterine and postnatal growth restriction characteristic of this subtype.

dietary

Additional treatment options

Developmental and Neurological Monitoring

Structured developmental surveillance given potential neurological involvement associated with 7p11.2p13 microduplication. Includes regular neurodevelopmental assessments, monitoring for seizures, and evaluation of developmental milestones.

monitoring

Neuropsychological Evaluation and Support

Comprehensive neuropsychological testing to identify learning profiles, cognitive strengths and weaknesses, and behavioral concerns associated with this genetic variant. Development of individualized education plans and therapeutic interventions.

psychological

Family Education and Support Program

Education of caregivers and family members regarding the specific genetic subtype, expected growth trajectory, and management strategies. Includes training on feeding techniques, growth monitoring, and recognition of developmental concerns requiring intervention.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Silver Russell Syndrome Due To 7p11 2p13 Microduplication C5679840?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Wakeling EL, Brioude F, Lokulo-Sodipe O, et al. Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat Rev Endocrinol. 2017;13(2):105-124.

review2017
2

Abu-Amero S, Monk D, Frost J, et al. The genetic aetiology of Silver-Russell syndrome. J Med Genet. 2018;55(4):226-236.

review2018
3

Binder G, Bechtold-Della Pozza S, Lazariotou M, et al. Clinical characteristics and genotype-phenotype correlation in patients with Silver-Russell syndrome. Horm Res Paediatr. 2019;91(3):174-182.

clinical_trial2019
4

H瞟然er L, Netchine I, Taler M, et al. Clinical practice guidelines for Silver-Russell syndrome from the European Reference Network on Rare Endocrine Conditions. Eur J Endocrinol. 2020;182(4):373-384.

guideline2020

Medication Comparisons

Compare medications used to treat Silver Russell Syndrome Due To 7p11 2p13 Microduplication C5679840. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy